AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
GeneMax Corp. announces agreement for the production of TAP cancer vaccine.
2003 OCT 8 - (NewsRx.com & NewsRx.net) -- GeneMax Corp. (GMXX) announced an amended contractual agreement with Molecular Medicine BioServices, Inc., of San Diego, California, for the production of its clinical vector for delivery of the TAP genes (transporters associated with antigen processing) used in GeneMax's lead product, an immunotherapy aimed to treat a wide variety of carcinomas that include lung cancers, liver cancers, kidney cancers, head and neck cancers, breast cancers, melanomas, prostate cancers, colorectal cancers, and cervical cancers.
The new production contract incorporates the use of a proprietary adenovirus-based vectoral technology from Crucell, which was licensed and announced by GeneMax in August 2003.
The new contract is based on production of sufficient vaccine to conduct the balance of preclinical work as well as phase I/IIa clinical trials. The contract defines that the product is to be tested by an independent laboratory. ...
- GeneMax Corp. appoints Edward C. Farrauto as Chief Financial Officer.
- Press release article from: PR Newswire June 17, 2004 700+ words
GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt: GX1) GeneMax announced...of GeneMax and its subsidiaries effective June 16, 2004. About GeneMax Corp.: GeneMax Corp. is a biotechnology company specializing in the discovery and development...
- GeneMax Corp. Announces License for Technology Designed to Identify Small...
- Press release article from: PR Newswire February 19, 2004 700+ words
GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt and Berlin: GX1) today...kill them and thereby eliminate tumors from the body. About GeneMax Corp.: GeneMax Corp. is a biotechnology company specializing in the discovery and development...
- GeneMax Corp. Announces Clarifications to December 9, 2002 Dow Jones News Story...
- Press release article from: PR Newswire December 10, 2002 700+ words
GeneMax Corp. (the "Company")(OTC Bulletin...Eduverse.com was subsequently renamed GeneMax Corp. After completion of the reverse takeover and consolidation, the GeneMax Corp. share option plan was comprised of...
- GeneMax Corp. reports advanced human TAP cancer vaccine successful in animal...
- Press release article from: PR Newswire July 20, 2004 700+ words
GENEMAX CORP. (OTCBB Symbol - GMXX, FWB Symbol - GX1, WKN: 645096, ISN: US36870Q1031) GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt...714-1225 Fax: (604) 331-0877 GeneMax Corp. - Suite 400 - 1681 Chestnut Street...
- GeneMax Corp. appoints Konstantine Sarafis as Chief Operating Officer.
- Press release article from: PR Newswire August 31, 2004 700+ words
GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt: GX1) GeneMax announced...marketing and he is well versed in corporate governance issues. About GeneMax Corp.: GeneMax Corp. is a biotechnology company specializing in the discovery and development...
- GeneMax Corp. Announces Agreement with Molecular Medicine BioServices, Inc. for...
- Press release article from: PR Newswire September 9, 2003 700+ words
GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt and Berlin: GX1) today...clinical, preparing for Phase I/IIa Clinical Trials. About GeneMax Corp.: GeneMax Corp. is a biotechno
- GeneMax Corp. announces agreement with Molecular Medicine BioServices, Inc. for...
- Press release article from: PR Newswire September 10, 2003 700+ words
...Blaine, Washington, September 10 /PRNewswire/ -- GeneMax Corp. - today announced an amended contractual agreement...preparing for Phase I/IIa Clinical Trials. - About GeneMax Corp GeneMax Corp. is a biotechn
- GeneMax Corp. Operational Update - Advancing Towards Clinical Trials with TAP...
- Press release article from: PR Newswire October 27, 2003 700+ words
GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt and Berlin: GX1) today...clinical, preparing for Phase I/IIa Clinical Trials. About GeneMax Corp.: GeneMax Corp. is a biotechnology company specializing in the discovery and development...